Actionnariat et activité des initiés pour Esperion Therapeutics, Inc. (ESPR): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $3.18 |
| Capitalisation | $661M |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-07-13 | Hoffman Robert E. | D-Return | 85,153 | $85 |
| 2026-07-13 | Hoffman Robert E. | D-Return | 40,000 | $56K |
| 2026-07-13 | Hoffman Robert E. | D-Return | 7,040 | $6K |
| 2026-07-13 | CARROLL J MARTIN | D-Return | 177,523 | $178 |
| 2026-07-13 | CARROLL J MARTIN | D-Return | 21,000 | $29K |
| 2026-07-13 | CARROLL J MARTIN | D-Return | 32,500 | $73K |
| 2026-07-13 | CARROLL J MARTIN | D-Return | 44,000 | $38K |
| 2026-07-13 | Shepard Jay | D-Return | 164,472 | $164 |
| 2026-07-13 | Shepard Jay | D-Return | 21,000 | $29K |
| 2026-07-13 | Shepard Jay | D-Return | 32,500 | $73K |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $38.2M | $34.5M | $37.0M | $166.1M | $305.0M | $208.9M | $124.8M | $82.2M | $144.8M | $167.9M |
| Placements à Court Terme | 0 | 0 | 0 | $34.7M | 0 | $50.4M | $42.1M | 0 | 0 | 0 |
| Créances | 0 | 0 | 0 | 0 | $12.4M | $22.9M | $33.7M | $48.5M | $80.1M | $140.2M |
| Stocks | 0 | 0 | 0 | 0 | $16.1M | $34.4M | $35.2M | $65.6M | $94.5M | $105.1M |
| Actifs Courants | $213.6M | $203.9M | $142.6M | $211.7M | $345.9M | $329.0M | $246.7M | $201.1M | $338.0M | $462.6M |
| Immobilisations Corporelles | $674000 | $435000 | $520000 | $2.7M | $7.3M | $2.6M | $1.2M | $4.7M | $5.8M | $3.3M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | $56000 | $56000 | $56000 | $56000 | $56000 | $56000 | $56000 | $56000 | $56000 | $56000 |
| Actifs Totaux | $245.2M | $277.8M | $143.5M | $214.4M | $353.3M | $381.6M | $247.9M | $205.8M | $343.8M | $465.9M |
| Dettes Fournisseurs | $4.6M | $20.4M | $44.9M | $28.9M | $52.0M | $17.6M | $23.0M | $31.7M | $51.6M | $65.1M |
| Dette à Court Terme | $1.7M | $1.0M | 0 | 0 | 0 | $12.7M | $25.1M | $34.8M | $102.2M | $89.7M |
| Passifs Courants | $15.6M | $33.1M | $64.3M | $66.1M | $94.1M | $73.4M | $92.3M | $156.2M | $246.2M | $300.8M |
| Dette à Long Terme | $1.0M | 0 | 0 | 0 | $179.4M | $258.3M | $259.9M | $501.5M | $483.7M | $457.6M |
| Passifs Totaux | $16.6M | $33.1M | $64.3M | $194.5M | $449.4M | $578.5M | $571.7M | $660.8M | $732.5M | $767.9M |
| Réserves | -$229.2M | -$396.3M | -$598.1M | -$695.3M | -$838.8M | -$1.11B | -$1.34B | -$1.55B | -$1.60B | -$1.62B |
| Capitaux Propres | $228.6M | $244.7M | -$598.1M | $19.9M | -$96.1M | -$196.9M | -$323.8M | -$455.0M | -$388.7M | -$302.0M |
| Dette Totale | $2.7M | $1.0M | 0 | $1.6M | $185.4M | $260.2M | $260.9M | $540.9M | $591.2M | $548.0M |
| Dette Nette | -$35.4M | -$33.4M | -$37.0M | -$199.2M | -$119.6M | $863000 | $94.1M | $458.7M | $446.5M | $380.1M |
| Fonds de Roulement | $198.0M | $170.8M | $78.3M | $145.6M | $251.8M | $255.6M | $154.4M | $44.8M | $91.8M | $161.8M |
Santé financière
| Dette / Capitaux propres | -1.77 |
| Ratio de liquidité | 1.53 |
| Piotroski F-Score | 5 |
| Altman Z-Score | -2.57 |
Rentabilité
| Rentabilité des capitaux propres | 1.99% |
| Rentabilité du capital investi | 30.98% |
| Rentabilité des actifs | -1.60% |
| Marge brute | 65.00% |
| Marge opérationnelle | 18.12% |
| Marge nette | -1.77% |
Entreprises liées: AGIO · COLL · EBS · HRTX · KPTI · PTCT
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de ESPR: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions